Low-level Laser Therapy with Novel Array of Light Source and Individualized Program for Treatment of Androgenetic Alopecia: A 16-week, Randomized, Double-blind, Sham Device-controlled Study
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Objectives Low-level laser therapy (LLLT) is used widely to promote hair growth in androgenetic alopecia (AGA). This study examined the clinical efficacy and safety of a home-use LLLT device with a newly designed array of light sources and software optimized for individual types of AGA. Materials and Methods The study was a randomized, double-blind, sham device-controlled trial. Forty-eight subjects (39 men and nine women) were assigned randomly in a 2:1 ratio to use either the test device (LG Pra’L HGN1, LG electronics, Korea) or sham device. The subjects used the LLLT device three times a week for 16 weeks. Phototrichogram was used to measure the hair density and hair thickness at 0, 8, and 16-weeks. Adverse events were closely monitored. Results After 16 weeks of using the device, the test group showed a significant increase in hair density and hair thickness compared to the control. In the test group, the hair density increased 6.96 counts/cm2 at eight weeks and 13.67 counts/cm2 at 16 weeks from the baseline. The hair thickness increased 7.21 μm at eight weeks and 11.80 μm at 16 weeks compared to the baseline. Conclusion The home-use LLLT device with a novel array of light sources and an individualized program according to the types of hair loss appears to be an effective and safe treatment modality for both male and female AGA patients.
Abstract
Background and Objectives Low-level laser therapy (LLLT) is used widely to promote hair growth in androgenetic alopecia (AGA). This study examined the clinical efficacy and safety of a home-use LLLT device with a newly designed array of light sources and software optimized for individual types of AGA. Materials and Methods The study was a randomized, double-blind, sham device-controlled trial. Forty-eight subjects (39 men and nine women) were assigned randomly in a 2:1 ratio to use either the test device (LG Pra’L HGN1, LG electronics, Korea) or sham device. The subjects used the LLLT device three times a week for 16 weeks. Phototrichogram was used to measure the hair density and hair thickness at 0, 8, and 16-weeks. Adverse events were closely monitored. Results After 16 weeks of using the device, the test group showed a significant increase in hair density and hair thickness compared to the control. In the test group, the hair density increased 6.96 counts/cm2 at eight weeks and 13.67 counts/cm2 at 16 weeks from the baseline. The hair thickness increased 7.21 μm at eight weeks and 11.80 μm at 16 weeks compared to the baseline. Conclusion The home-use LLLT device with a novel array of light sources and an individualized program according to the types of hair loss appears to be an effective and safe treatment modality for both male and female AGA patients.
참고문헌 (14)
- Cash TF, "Psychological effects of androgenetic alopecia on women : comparisons with balding men and with female control subjects", J Am Acad Dermatol, 29, pp.568~575 (1993)
- Sung Hyub Han, "Quality of Life Assessment in Male Patients with Androgenetic Alopecia: Result of a Prospective, Multicenter Study", Annals of Dermatology, 24(3), pp.311~318 (2012), 대한피부과학회[DOI]
- 장우선, "The Annual Changes of Clinical Manifestation of Androgenetic Alopecia Clinic in Korean Males and Females: A Outpatient-Based Study", Annals of Dermatology, 25(2), pp.181~188 (2013), 대한피부과학회
- Tosti A, "Androgenetic alopecia in children : report of 20 cases", Br J Dermatol, 152, pp.556~559 (2005)
- Rebora A, "Pathogenesis of androgenetic alopecia", J Am Acad Dermatol, 50, pp.777~779 (2004)
- Avci P, "Low-level laser(light)therapy(LLLT)for treatment of hair loss", Lasers Surg Med, 46, pp.144~151 (2014)
- Afifi L, "Low-level laser therapy as a treatment for androgenetic alopecia", Lasers Surg Med, 49, pp.27~39 (2017)
- Kim H, "Low-level light therapy for androgenetic alopecia : a 24-week, randomized, double-blind, sham device-controlled multicenter trial", Dermatol Surg, 39, pp.1177~1183 (2013)
- Gupta AK, "A critical assessment of the evidence for low-level laser therapy in the treatment of hair loss", Dermatol Surg, 43, pp.188~197 (2017)
- Blumeyer A, "Evidence-based(S3)guideline for the treatment of androgenetic alopecia in women and in men", J Dtsch Dermatol Ges, 9, pp.S1~S57 (2011)
- Avram MR, "The current role of laser", light sources in the treatment of male and female pattern hair loss, 2007, pp.9, 27~28
- Ghanaat M, "Types of hair loss and treatment options, including the novel low-level light therapy and its proposed mechanism", South Med J, 103, pp.917~921 (2010)
- Suchonwanit P, "Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women : a 24-week, randomized, double-blind, sham device-controlled trial", Lasers Med Sci, 34, pp.1107~1114 (2019)
- Hirshburg JM, "Adverse effects and safety of 5-alpha reductase inhibitors(finasteride, dutasteride) : a systematic review", J Clin Aesthet Dermatol, 9, pp.56~62 (2016)